Katerina Pardali
Associate Principal Scientist
Radiology
AstraZeneca Sdn Bhd
Malaysia
Biography
Having completed PhD in molecular cell biology at Uppsala University in 2007, joined AstraZeneca as a postdoctoral researcher in 2009, which offered a great opportunity to introduce in situ proximity ligation assay (isPLA) on projects within the analgesia and Alzheimer’s disease areas. Successfully established isPLA technology into the company, to strengthen the target validation and show activation of target molecules in human tissue and translatable animal models.
Research Interest
Having completed PhD in molecular cell biology at Uppsala University in 2007, joined AstraZeneca as a postdoctoral researcher in 2009, which offered a great opportunity to introduce in situ proximity ligation assay (isPLA) on projects within the analgesia and Alzheimer’s disease areas. Successfully established isPLA technology into the company, to strengthen the target validation and show activation of target molecules in human tissue and translatable animal models.
